![Irina Staatz-Granzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Irina Staatz-Granzer
Président chez
INNATE PHARMA
Fortune : 46 489 $ au 30/06/2026
Profil
Irina Staatz-Granzer is the founder of Staatz Business Development & Strategy.
Current jobs include Chairman at Innate Pharma SA since 2025, Chairman at Pharma-Lizenz-Club Deutschland, Chairman at Talix Therapeutics NV since 2017, and Member-Supervisory Board at Aelis Farma SA since 2022.
Former jobs include Chief Executive Officer at BioNet Pharma GmbH, Chairman & Chief Executive Officer at BliNK Biomedical SAS, Chairman at BliNK Therapeutics Ltd., Co-Chairman Supervisory Board at Emergence Therapeutics AG, Director at U3 Pharma AG from 2009 to 2010, Chief Business Officer at FIBREX Medical, Inc. from 2008 to 2013, and Principal at HERMAL Kurt Herrmann GmbH & Co. oHG.
Education includes a doctorate from Eberhard Karls Universität Tübingen and an undergraduate degree from Philipps University of Marburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INNATE PHARMA SA CLASS A 0,03 % | 30/03/2026 | 25 100 ( 0,03 % ) | 46 489 $ | 30/06/2026 |
Postes actifs de Irina Staatz-Granzer
| Sociétés | Poste | Début |
|---|---|---|
| INNATE PHARMA | Président | 01/01/2024 |
| AELIS FARMA | Directeur/Membre du Conseil | 01/01/2022 |
Staatz Business Development & Strategy | Fondateur | 19/07/2010 |
Pharma-Lizenz-Club Deutschland | Président | - |
Talix Therapeutics NV | Président | 01/01/2017 |
Anciens postes connus de Irina Staatz-Granzer
| Sociétés | Poste | Fin |
|---|---|---|
FIBREX Medical, Inc.
 FIBREX Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bio-pharmaceutical research development services | Corporate Officer/Principal | 05/02/2013 |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Président | - |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology Develops antibody-based therapeutics | Directeur Général | - |
BliNK Therapeutics Ltd.
 BliNK Therapeutics Ltd. BiotechnologyHealth Technology Produces therapeutic monoclonal antibodies | Président | - |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Irina Staatz-Granzer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
FIBREX Medical, Inc.
FIBREX Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bio-pharmaceutical research development services | Commercial Services |
HERMAL Kurt Herrmann GmbH & Co. oHG
 HERMAL Kurt Herrmann GmbH & Co. oHG Pharmaceuticals: MajorHealth Technology Provides skin care products | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
U3 Pharma AG
 U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment | Commercial Services |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNet Pharma GmbH
 BioNet Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in development of medical devices, pharmaceutical drugs and regenerative medical products | Commercial Services |
Staatz Business Development & Strategy | |
Pharma-Lizenz-Club Deutschland | |
BliNK Therapeutics Ltd.
BliNK Therapeutics Ltd. BiotechnologyHealth Technology Produces therapeutic monoclonal antibodies | Health Technology |
Aelis Farma SA
 Aelis Farma SA BiotechnologyHealth Technology Operates as a biotechnology company which develops drugs for brain diseases | Health Technology |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology Develops antibody-based therapeutics | Health Technology |
Talix Therapeutics NV | |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Health Technology |
